Analytical Data
-
基因名
SLC25A45
- Application
-
别名
SLC25A45; Solute carrier family 25 member 45
-
种属
Human
-
表达系统
Baculovirus
-
标签
N-MBP;C-Flag;N-8*His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q8N413
-
表达区间
P2-G288
-
蛋白长度
Partial
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SLC25A45, a member of the solute carrier family of proteins, is primarily known for its role as a mitochondrial transporter. Recent research has highlighted its involvement in various cellular processes, including mitochondrial metabolism, calcium homeostasis, and apoptosis regulation. Dysregulation of SLC25A45 has been implicated in several diseases, such as metabolic disorders and neurodegenerative conditions, making it a potential target for therapeutic interventions. Moreover, the study of SLC25A45 recombinant proteins has become essential for understanding its structure-function relationship, elucidating its transport mechanisms, and exploring its role in cellular homeostasis. By producing recombinant SLC25A45, researchers can investigate its biochemical properties and interactions with other mitochondrial components. This research not only offers insights into the fundamental biology of mitochondrial transporters but also provides a foundation for developing novel treatments for diseases linked to mitochondrial dysfunction. As we delve deeper into the functional characteristics of SLC25A45 through recombinant protein studies, we aim to uncover its potential as a biomarker or therapeutic target in mitochondrial-related pathologies, thus contributing to the broader understanding of mitochondrial biology and its implications in human health.
